Paper2003990
Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.
Raina V and 3 others. Br J Cancer, 1991. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Papers, record 2003990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2003990
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxycholecalciferols | Major topic |
| Lymphoma, Follicular | Major topic |
| Calcitriol | |
| Calcium | |
| Female | |
| Humans | |
| Male |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,895,862 | 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. | Cancer Res | 1982 | https://conductscience.org/library/papers/6895862 | PubMed |
| 2 | 6,277,475 | Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. | Cancer Res | 1982 | https://conductscience.org/library/papers/6277475 | PubMed |
| 3 | 6,427,926 | 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. | Science | 1984 | https://conductscience.org/library/papers/6427926 | PubMed |
| 4 | 6,611,355 | 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6611355 | PubMed |
| 5 | 6,548,796 | The natural history of initially untreated low-grade non-Hodgkin's lymphomas. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6548796 | PubMed |
| 6 | 2,996,693 | Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/2996693 | PubMed |
| 7 | 3,754,600 | 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). | J Steroid Biochem | 1986 | https://conductscience.org/library/papers/3754600 | PubMed |
| 8 | 3,024,816 | Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. | Cancer Res | 1987 | https://conductscience.org/library/papers/3024816 | PubMed |
| 9 | 3,027,709 | Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3027709 | PubMed |
| 10 | 3,110,950 | Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. | Science | 1987 | https://conductscience.org/library/papers/3110950 | PubMed |
| 11 | 2,829,219 | Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2829219 | PubMed |
| 12 | 1,089,470 | Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. | Cancer | 1975 | https://conductscience.org/library/papers/1089470 | PubMed |
| 13 | 1,030,780 | Spontaneous regression of hematologic cancers. | Natl Cancer Inst Monogr | 1976 | https://conductscience.org/library/papers/1030780 | PubMed |
| 14 | 7,459,811 | Reporting results of cancer treatment. | Cancer | 1981 | https://conductscience.org/library/papers/7459811 | PubMed |
| 15 | 6,257,495 | 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. | Endocrinology | 1981 | https://conductscience.org/library/papers/6257495 | PubMed |
| 16 | 6,310,748 | 1,25-dihydroxyvitamin D3 receptors in human leukocytes. | Science | 1983 | https://conductscience.org/library/papers/6310748 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,677,358 | Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39677358 | PubMed |
| 24,772,087 | The future of vitamin D analogs. | Front Physiol | 2014 | https://conductscience.org/library/papers/24772087 | PubMed |
| 21,119,732 | Vitamin D, disease and therapeutic opportunities. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/21119732 | PubMed |
| 21,048,153 | Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. | Blood | 2011 | https://conductscience.org/library/papers/21048153 | PubMed |
| 20,713,849 | Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20713849 | PubMed |
| 20,562,184 | Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. | Am J Epidemiol | 2010 | https://conductscience.org/library/papers/20562184 | PubMed |
| 20,373,010 | A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults. | Cancer Causes Control | 2010 | https://conductscience.org/library/papers/20373010 | PubMed |
| 19,832,043 | Vitamin D and non-Hodgkin lymphoma risk in adults: a review. | Cancer Invest | 2009 | https://conductscience.org/library/papers/19832043 | PubMed |
| 19,035,445 | A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19035445 | PubMed |
| 14,586,212 | Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/14586212 | PubMed |
| 8,912,548 | Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8912548 | PubMed |
| 8,398,690 | The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8398690 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2003990
GET https://conductscience.org/api/papers/v1/2003990/authors